18F-fluoromisonidazole PET uptake is correlated with hypoxia-inducible factor-1a expression in oral squamous cell carcinoma

50Citations
Citations of this article
45Readers
Mendeley users who have this article in their library.

Abstract

Hypoxia is a common feature of cancer and a prognostic factor for many types of cancer. 18F-fluoromisonidazole (18F-FMISO) PET can detect tumor hypoxia noninvasively. Hypoxia-inducible factor- 1 (HIF-1) is a key player in the transcriptional response to low oxygen tension in many types of cancer. Its activity is mainly dependent on the stability and modification of HIF-1α, which is a composition of HIF-1. However, it is unclear whether 18F-FMISO PET can identify HIF-1α expression in oral squamous cell carcinoma (OSCC). The present study was performed to elucidate the correlation between 18F-FMISO PET findings and HIF-1α expression in OSCC. Methods: Twenty-three patients (age range, 42- 84 y; 15 men, 8 women) with OSCC were enrolled in this study. The T-stages of cancer were T1 in 1 patient, T2 in 9, T3 in 2, and T4a in 11. The N-stages were N0 in 13 patients, N1 in 5, and N2 in 5. Each patient underwent 18F-FMISO and 18F-FDG PET before surgery, and the maximum standardized uptake value (SUVmax) of both PET studies was measured. HIF-1α expression in the operation materials was evaluated by immunohistochemical staining. The SUVmax of both PET studies and HIF-1α findings were compared statistically. Results: 18F-FMISO PET detected uptake in the primary site in 14 of the 23 patients (61%). The median SUVmax of 18F-FMISO and 18F-FDG PET in the primary site was 1.83 (range, 0.8-2.7) and 16.5 (range, 1.0-32.3), respectively. There was a weak significant correlation between 18F-FMISO and 18F-FDG PET SUVmax (P 5 0.02, r 5 0.48). HIF-1α expression was clearly detected in 11 of the 23 patients (48%). The 18F-FMISO PET SUV max was significantly higher in the HIF-1α- positive cases than in the HIF-1α-negative cases (median, 2.1; range, 1.5-2.4, vs. median, 1.6; range, 0.8-2.0, respectively) (P 5 0.002). However, there were no significant correlations between 18F-FDG PET SUVmax and HIF-1α expression (median, 21.8; range, 7.7-29.1 vs. 1.0-32.2) (P 5 0.06). Conclusion: 18F-FMISO uptake in the primary site of OSCC indicates a hypoxic environment with HIF-1α expression. © 2013 by the Society of Nuclear Medicine.

Cite

CITATION STYLE

APA

Sato, J., Kitagawa, Y., Yamazaki, Y., Hata, H., Okamoto, S., Shiga, T., … Tamaki, N. (2013). 18F-fluoromisonidazole PET uptake is correlated with hypoxia-inducible factor-1a expression in oral squamous cell carcinoma. Journal of Nuclear Medicine, 54(7), 1060–1065. https://doi.org/10.2967/jnumed.112.114355

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free